“Revolutionizing Social Impact Reporting: YourCause Teams Up with Blackbaud and True Impact to Provide Advanced AI-Driven Insights and Storytelling for Companies”

Integration of True Impact Measurement Data into Blackbaud Impact Edge™ Real-Time Insights for CSR Initiatives CHARLESTON, S.C. , Jan. 28, 2025 /PRNewswire/ — Blackbaud (NASDAQ: BLKB), the leading provider of software for powering social impact, has announced an industry-leading partnership with True Impact®, a social impact measurement platform that helps social change leaders at purpose-driven…

Read More

“MicroStrategy’s Q4 Report: A Net Loss of $670.8 Million, But a New BTC Gain of $10 Billion”

Welcome to our Blog! The Company fka MicroStrategy’s Revenue Decline Recently, the company formerly known as MicroStrategy reported total revenues of $120.7 million, which represented a 3% decrease from the previous year and fell short of estimates by about $3 million. This news has sparked discussions and speculation among investors and industry analysts alike. Impact…

Read More

Japan’s FX Intervention Report: Credit Agricole Says Yes! What This Means for the JPY – A Heartfelt Analysis

Credit Agricole Examines Impact of Upcoming Events on Japanese Yen Introduction Credit Agricole recently provided insights into upcoming events that could have a significant impact on the Japanese yen. Of particular interest is the Ministry of Finance’s (MoF) monthly FX Intervention Operations report, scheduled for release this Friday. Additionally, the focus is on the potential…

Read More

Revolutionizing R-R cHL Treatment: Affimed’s Acimtamig and AlloNK Combination Proves Safe and Effective for Relapsed/Refractory Classical Hodgkin Lymphoma Patients

Revolutionizing R-R cHL Treatment: Affimed’s Acimtamig and AlloNK Combination Proves Safe and Effective for Relapsed/Refractory Classical Hodgkin Lymphoma Patients MANNHEIM, Germany, Dec. 08, 2024 (GLOBE NEWSWIRE) — Affimed N.V. (Nasdaq: AFMD) Affimed, a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, today announced the presentation of data in a…

Read More